Background
Kristine Glunde, Ph.D., is a Professor in the Johns Hopkins Medicine Division of Cancer Imaging Research within the Department of Radiology and Radiological Science and a member of the Johns Hopkins Kimmel Cancer Center. Her area of specialty is multimodal molecular and cellular imaging of breast and prostate cancer.
Dr. Glunde earned her doctoral degree in biochemistry – as well as a diploma in chemistry and biochemistry – from Germany’s University of Bremen. She completed a postdoctoral fellowship in cancer imaging research at Johns Hopkins and joined the faculty in 2003.
Dr. Glunde’s laboratory investigates cancer at the cellular and molecular level with the goal of better understanding, diagnosing, treating and preventing it. Her team has developed novel near-infrared optical imaging agents and demonstrated their feasibility for in vivo optical imaging of breast tumor models.
Dr. Glunde’s research interests include multimodal molecular and cellular imaging, magnetic resonance spectroscopic imaging, optical imaging, mass spectrometry imaging in cancer and cancer metabolism – particularly in breast and prostate cancer.
She is currently leading a number of National Institutes of Health-funded studies.
Dr. Glunde is a member of professional organizations that include the International Society for Magnetic Resonance in Medicine, American Association for Cancer Research, the American Society for Cell Biology and the Society for Molecular Imaging.
She has served as a grant reviewer for entities including the U.S. Department of Defense, National Institutes of Health and European Science Foundation, as well as a reviewer for publications such as The Lancet Oncology, Clinical Cancer Research, Journal of Neuroscience Research, Molecular Imaging and Journal of Medicinal Chemistry.
Patient Ratings & Comments
The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.